{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:30:53Z","timestamp":1793320253337,"version":"4.5.0"},"reference-count":46,"publisher":"BMJ","issue":"7","funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1068040"],"award-info":[{"award-number":["1068040"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1138004"],"award-info":[{"award-number":["1138004"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1142006"],"award-info":[{"award-number":["1142006"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1175134"],"award-info":[{"award-number":["1175134"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1179092"],"award-info":[{"award-number":["1179092"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1201338"],"award-info":[{"award-number":["1201338"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["115010"],"award-info":[{"award-number":["115010"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Research Future Fund - Australian Government","award":["1201338"],"award-info":[{"award-number":["1201338"]}]},{"name":"Lions Rheumatism and Arthritis Medical Research Foundation","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["190100091"],"award-info":[{"award-number":["190100091"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union's Seventh Framework Program","award":["FP7\/2007-2013"],"award-info":[{"award-number":["FP7\/2007-2013"]}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}],"id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Technolgy Sydney","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2022,7,15]]},"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Severe neutrophilic asthma is resistant to treatment with glucocorticoids. The immunomodulatory protein macrophage migration inhibitory factor (MIF) promotes neutrophil recruitment to the lung and antagonises responses to glucocorticoids. We hypothesised that MIF promotes glucocorticoid resistance of neutrophilic inflammation in severe asthma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We examined whether sputum MIF protein correlated with clinical and molecular characteristics of severe neutrophilic asthma in the Unbiased Biomarkers for the Prediction of Respiratory Disease Outcomes (U-BIOPRED) cohort. We also investigated whether MIF regulates neutrophilic inflammation and glucocorticoid responsiveness in a murine model of severe asthma in vivo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>MIF protein levels positively correlated with the number of exacerbations in the previous year, sputum neutrophils and oral corticosteroid use across all U-BIOPRED subjects. Further analysis of MIF protein expression according to U-BIOPRED-defined transcriptomic-associated clusters (TACs) revealed increased MIF protein and a corresponding decrease in annexin-A1 protein in TAC2, which is most closely associated with airway neutrophilia and NLRP3 inflammasome activation. In a murine model of severe asthma, treatment with the MIF antagonist ISO-1 significantly inhibited neutrophilic inflammation and increased glucocorticoid responsiveness. Coimmunoprecipitation studies using lung tissue lysates demonstrated that MIF directly interacts with and cleaves annexin-A1, potentially reducing its biological activity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our data suggest that MIF promotes glucocorticoid-resistance of neutrophilic inflammation by reducing the biological activity of annexin-A1, a potent glucocorticoid-regulated protein that inhibits neutrophil accumulation at sites of inflammation. This represents a previously unrecognised role for MIF in the regulation of inflammation and points to MIF as a potential therapeutic target for the management of severe neutrophilic asthma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/thorax-2021-218555","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T13:22:10Z","timestamp":1667827330000},"page":"661-673","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":32,"title":["Macrophage migration inhibitory factor promotes glucocorticoid resistance of neutrophilic inflammation in a murine model of severe asthma"],"prefix":"10.1136","volume":"78","clinical-trial-number":[{"clinical-trial-number":"nct01982162","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Venkata Sita Rama Raju","family":"Allam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stelios","family":"Pavlidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin Zounemat","family":"Kermani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ke","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M","family":"Hansbro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Phipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric F","family":"Morand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratko","family":"Djukanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Sterk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kian Fan","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Adcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria B","family":"Sukkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,11,7]]},"reference":[{"key":"2024051319533178000_78.7.661.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00157-9"},{"key":"2024051319533178000_78.7.661.2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.chest.2019.08.2192","article-title":"Meeting the challenge of identifying new treatments for type 2-Low neutrophilic asthma","volume":"157","author":"Kalchiem-Dekel","year":"2020","journal-title":"Chest"},{"key":"2024051319533178000_78.7.661.3","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/14728222.2020.1786535","article-title":"Emerging therapeutic targets and preclinical models for severe asthma","volume":"24","author":"Galv\u00e3o","year":"2020","journal-title":"Expert Opin Ther Targets"},{"key":"2024051319533178000_78.7.661.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31281-3"},{"key":"2024051319533178000_78.7.661.5","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-206067"},{"key":"2024051319533178000_78.7.661.6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.pupt.2017.05.012","article-title":"Effects of the CXCR2 antagonist AZD5069 on lung neutrophil recruitment in asthma","volume":"45","author":"Watz","year":"2017","journal-title":"Pulm Pharmacol Ther"},{"key":"2024051319533178000_78.7.661.7","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.158.2.9707086"},{"key":"2024051319533178000_78.7.661.8","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-10-33"},{"key":"2024051319533178000_78.7.661.9","doi-asserted-by":"publisher","DOI":"10.1096\/fj.14-256636"},{"key":"2024051319533178000_78.7.661.10","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201800480R"},{"key":"2024051319533178000_78.7.661.11","doi-asserted-by":"crossref","unstructured":"Lang T , Foote A , Lee J . MIF: implications in the pathoaetiology of systemic lupus erythematosus. Front Immunol;15:6.","DOI":"10.3389\/fimmu.2015.00577"},{"key":"2024051319533178000_78.7.661.12","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-019-0238-2"},{"key":"2024051319533178000_78.7.661.13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04581-2"},{"key":"2024051319533178000_78.7.661.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2019.03.002"},{"key":"2024051319533178000_78.7.661.15","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00105013"},{"key":"2024051319533178000_78.7.661.16","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jaci.2017.02.045","article-title":"Sputum transcriptomics reveal upregulation of IL-1 receptor family members in patients with severe asthma","volume":"141","author":"Rossios","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"2024051319533178000_78.7.661.17","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201609-1830OC"},{"key":"2024051319533178000_78.7.661.18","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02135-2016","article-title":"T-Helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED","volume":"49","author":"Kuo","year":"2017","journal-title":"Eur Respir J"},{"key":"2024051319533178000_78.7.661.19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-1-4939-9936-1_18","article-title":"Investigating MIF in mouse models of severe corticosteroid-resistant neutrophilic asthma","volume":"2080","author":"Allam","year":"2020","journal-title":"Methods Mol Biol"},{"key":"2024051319533178000_78.7.661.20","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00779-2015"},{"key":"2024051319533178000_78.7.661.21","doi-asserted-by":"crossref","first-page":"15056","DOI":"10.1038\/cddiscovery.2015.56","article-title":"Secondary necrotic neutrophils release interleukin-16C and macrophage migration inhibitory factor from stores in the cytosol","volume":"1","author":"Roth","year":"2015","journal-title":"Cell Death Discov"},{"key":"2024051319533178000_78.7.661.22","doi-asserted-by":"publisher","DOI":"10.1038\/414920a"},{"key":"2024051319533178000_78.7.661.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0165-0"},{"key":"2024051319533178000_78.7.661.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2019.01.007"},{"key":"2024051319533178000_78.7.661.25","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200801-061OC"},{"key":"2024051319533178000_78.7.661.26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-270520"},{"key":"2024051319533178000_78.7.661.27","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-201180"},{"key":"2024051319533178000_78.7.661.28","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107555","article-title":"MIF inhibitor ISO-1 alleviates severe acute pancreatitis-associated acute kidney injury by suppressing the NLRP3 inflammasome signaling pathway","volume":"96","author":"Liu","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"2024051319533178000_78.7.661.29","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7915","article-title":"Extracellular MRP8\/14 is a regulator of \u03b22 integrin-dependent neutrophil slow rolling and adhesion","volume":"6","author":"Pruenster","year":"2015","journal-title":"Nat Commun"},{"key":"2024051319533178000_78.7.661.30","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2009.120741"},{"key":"2024051319533178000_78.7.661.31","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93534","article-title":"ALX receptor ligands define a biochemical endotype for severe asthma","volume":"2","author":"Ricklefs","year":"2017","journal-title":"JCI Insight"},{"key":"2024051319533178000_78.7.661.32","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jaip.2018.08.024","article-title":"Children with Neutrophil-Predominant severe asthma have proinflammatory neutrophils with enhanced survival and impaired clearance","volume":"7","author":"Grunwell","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024051319533178000_78.7.661.33","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M702876200"},{"key":"2024051319533178000_78.7.661.34","doi-asserted-by":"crossref","first-page":"7639","DOI":"10.1016\/S0021-9258(18)47614-4","article-title":"Purification and characterization of proteolytic fragments of lipocortin I that inhibit phospholipase A2","volume":"262","author":"Huang","year":"1987","journal-title":"J Biol Chem"},{"key":"2024051319533178000_78.7.661.35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06941.x"},{"key":"2024051319533178000_78.7.661.36","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.200400895"},{"key":"2024051319533178000_78.7.661.37","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1000119"},{"key":"2024051319533178000_78.7.661.38","doi-asserted-by":"publisher","DOI":"10.1172\/JCI80911"},{"key":"2024051319533178000_78.7.661.39","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500886"},{"key":"2024051319533178000_78.7.661.40","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/imm.12135","article-title":"Macrophage migration inhibitory factor counterregulates dexamethasone induced annexin 1 expression and influences the release of eicosanoids in murine macrophages","volume":"140","author":"Yu","year":"2013","journal-title":"Immunol"},{"key":"2024051319533178000_78.7.661.41","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/art.38689","article-title":"Macrophage migration inhibitory factor inhibits the antiinflammatory effects of glucocorticoids via glucocorticoid-induced leucine zipper","volume":"66","author":"Fan","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2024051319533178000_78.7.661.42","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200535413"},{"key":"2024051319533178000_78.7.661.43","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.11.8148"},{"key":"2024051319533178000_78.7.661.44","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0804000"},{"key":"2024051319533178000_78.7.661.45","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.24156"},{"key":"2024051319533178000_78.7.661.46","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401722"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2021-218555","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T23:22:16Z","timestamp":1715642536000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2021-218555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,7]]},"references-count":46,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,6,15]]},"published-print":{"date-parts":[[2023,7]]}},"alternative-id":["10.1136\/thorax-2021-218555"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2021-218555","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,7]]}}}